EXHIBIT 1

 

JOINT FILING AGREEMENT

PURSUANT TO RULE 13d-1(k)

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. The undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.

 

Date: February 10, 2025 3i, LP
     
  By: 3i Management LLC,
         its General Partner
     
  By: /s/ Maier Joshua Tarlow
    Name: Maier Joshua Tarlow
    Title: Manager
     
  3i Management LLC
     
  By: /s/ Maier Joshua Tarlow
    Name: Maier Joshua Tarlow
    Title: Manager
     
  /s/ Maier Joshua Tarlow

 

 

 Maier Joshua Tarlow

 

BriaCell Therapeutics (NASDAQ:BCTXW)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos BriaCell Therapeutics.
BriaCell Therapeutics (NASDAQ:BCTXW)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos BriaCell Therapeutics.